Organotitanium Nucleophiles in Asymmetric Cross-Coupling Reaction: Stereoconvergent Synthesis of Chiral α-CF3 Thioethers | Journal of the American Chemical Society
![42206-94-0 | trans-Resveratrol Triacetate | Triacetyl Resveratrol; 3,4',5-Triacetoxy-trans-stilbene; 3,5,4'-Tri-O-acetylresveratrol; 5-[(1E)-2-[4-(Acetyloxy)phenyl]ethenyl]-1,3-benzenediol1,3-Diacetate; Resveratrol 3,5,4'-triacetate; | C20H18O6 | TRC 42206-94-0 | trans-Resveratrol Triacetate | Triacetyl Resveratrol; 3,4',5-Triacetoxy-trans-stilbene; 3,5,4'-Tri-O-acetylresveratrol; 5-[(1E)-2-[4-(Acetyloxy)phenyl]ethenyl]-1,3-benzenediol1,3-Diacetate; Resveratrol 3,5,4'-triacetate; | C20H18O6 | TRC](https://www.trc-canada.com/prod-img/R150055.png)
42206-94-0 | trans-Resveratrol Triacetate | Triacetyl Resveratrol; 3,4',5-Triacetoxy-trans-stilbene; 3,5,4'-Tri-O-acetylresveratrol; 5-[(1E)-2-[4-(Acetyloxy)phenyl]ethenyl]-1,3-benzenediol1,3-Diacetate; Resveratrol 3,5,4'-triacetate; | C20H18O6 | TRC
![Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei | bioRxiv Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/10/2020.03.08.982751/F16.large.jpg)
Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei | bioRxiv
![Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors | Journal of Medicinal Chemistry Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm300951u/asset/images/medium/jm-2012-00951u_0004.gif)
Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors | Journal of Medicinal Chemistry
![PDF] Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain. | Semantic Scholar PDF] Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c6e4767ba53aaf7b60b7691392e038c1fbf1cd7e/2-Figure1-1.png)
PDF] Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain. | Semantic Scholar
![1242567-09-4 | Balsalazide 3-Isomer | 3-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl]-2-hydroxybenzoic Acid; (E)-3-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic Acid; Balsalazide USP Impurity 2; | C₁₇H₁₅N₃O₆ | TRC 1242567-09-4 | Balsalazide 3-Isomer | 3-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl]-2-hydroxybenzoic Acid; (E)-3-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic Acid; Balsalazide USP Impurity 2; | C₁₇H₁₅N₃O₆ | TRC](https://www.trc-canada.com/prod-img/B116310.png)